Véronique Barban

1.0k total citations
20 papers, 812 citations indexed

About

Véronique Barban is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Véronique Barban has authored 20 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 9 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Véronique Barban's work include Mosquito-borne diseases and control (10 papers), Viral Infections and Vectors (6 papers) and Malaria Research and Control (5 papers). Véronique Barban is often cited by papers focused on Mosquito-borne diseases and control (10 papers), Viral Infections and Vectors (6 papers) and Malaria Research and Control (5 papers). Véronique Barban collaborates with scholars based in France, United States and Italy. Véronique Barban's co-authors include Jean Lang, Bruno Guy, Thomas P. Monath, Stephen Higgs, Farshad Guirakhoo, Nathalie Mantel, N. Sauze, Gilles Quérat, Robert Vigne and Yves Girerd-Chambaz and has published in prestigious journals such as PLoS ONE, Journal of Virology and Gene.

In The Last Decade

Véronique Barban

20 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Barban France 15 492 478 227 116 111 20 812
Patricia M. Repik United States 18 641 1.3× 629 1.3× 229 1.0× 99 0.9× 182 1.6× 26 1.0k
Ronald C. Weir Australia 15 718 1.5× 618 1.3× 204 0.9× 125 1.1× 76 0.7× 24 1.1k
Robert B. Tesh United States 17 407 0.8× 670 1.4× 187 0.8× 50 0.4× 46 0.4× 29 955
Inessa S. Levenbook United States 17 528 1.1× 770 1.6× 174 0.8× 67 0.6× 107 1.0× 45 1.2k
Marcos S. Freire Brazil 20 586 1.2× 546 1.1× 190 0.8× 80 0.7× 43 0.4× 31 831
Mathilde Guerbois United States 15 594 1.2× 562 1.2× 236 1.0× 66 0.6× 80 0.7× 17 898
Vladimir Yamshchikov United States 15 696 1.4× 597 1.2× 115 0.5× 105 0.9× 51 0.5× 27 877
Antonio V. Bordería France 16 336 0.7× 442 0.9× 186 0.8× 131 1.1× 325 2.9× 25 1.0k
John Catalan United States 13 863 1.8× 810 1.7× 181 0.8× 71 0.6× 38 0.3× 18 1.0k
Kym Lowry Australia 12 395 0.8× 373 0.8× 105 0.5× 36 0.3× 83 0.7× 24 707

Countries citing papers authored by Véronique Barban

Since Specialization
Citations

This map shows the geographic impact of Véronique Barban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Barban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Barban more than expected).

Fields of papers citing papers by Véronique Barban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Barban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Barban. The network helps show where Véronique Barban may publish in the future.

Co-authorship network of co-authors of Véronique Barban

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Barban. A scholar is included among the top collaborators of Véronique Barban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Barban. Véronique Barban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saulnier, Aure, et al.. (2018). Phages and vaccination: towards new opportunities?. Virologie. 24(1). 37–47. 1 indexed citations
2.
Mantel, Nathalie, et al.. (2018). Replacement of primary monkey kidney cells by L20B cell line in the test for effective inactivation of inactivated poliovirus vaccine. Journal of Virological Methods. 256. 77–84. 1 indexed citations
3.
4.
Barban, Véronique, et al.. (2015). Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs. PLoS ONE. 10(4). e0121518–e0121518. 32 indexed citations
5.
Barban, Véronique, et al.. (2013). Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain. Biologicals. 41(4). 238–246. 5 indexed citations
6.
Kazimírová, Mária, Nathalie Mantel, Mirko Slovák, et al.. (2012). Evaluation of Chimeric Yellow Fever 17D/Dengue Viral Replication in Ticks. Vector-Borne and Zoonotic Diseases. 12(11). 979–985. 6 indexed citations
7.
Barban, Véronique, Jorge L. Muñoz‐Jordán, Gilberto A. Santiago, et al.. (2012). Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric Yellow Fever 17D/Dengue viruses. Virology. 429(2). 91–98. 28 indexed citations
8.
Mantel, Nathalie, Yves Girerd-Chambaz, Christian Gény, et al.. (2011). Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses. Vaccine. 29(38). 6629–6635. 21 indexed citations
9.
Guy, Bruno, Farshad Guirakhoo, Véronique Barban, et al.. (2009). Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine. 28(3). 632–649. 221 indexed citations
10.
Guy, Bruno, Véronique Barban, Nathalie Mantel, et al.. (2009). Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model. American Journal of Tropical Medicine and Hygiene. 80(2). 302–311. 114 indexed citations
11.
Mantel, Nathalie, et al.. (2008). Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever–dengue vaccines. Journal of Virological Methods. 151(1). 40–46. 48 indexed citations
12.
Barban, Véronique, et al.. (2006). High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale production. Vaccine. 25(15). 2941–2950. 45 indexed citations
13.
Barrett, Alan D.T., Thomas P. Monath, Véronique Barban, Matthias Niedrig, & Dirk E. Teuwen. (2006). 17D yellow fever vaccines: New insights. Vaccine. 25(15). 2758–2765. 44 indexed citations
14.
Barban, Véronique, Gláucia Paranhos‐Baccalà, Catherine Manin, et al.. (2000). Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient. Microbiology. 81(2). 461–469. 16 indexed citations
15.
Levrero, Massimo, Véronique Barban, Maria Laura Avantaggiati, et al.. (1991). Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene. 101(2). 195–202. 55 indexed citations
16.
Vigne, Robert, Véronique Barban, Gilles Quérat, et al.. (1987). Transcription of visna virus during its lytic cycle: Evidence for a sequential early and late gene expression. Virology. 161(1). 218–227. 40 indexed citations
17.
Quérat, Gilles, Véronique Barban, N. Sauze, et al.. (1987). Characteristics of a novel lentivirus derived from South African sheep with pulmonary adenocarcinoma (jaagsiekte). Virology. 158(1). 158–167. 24 indexed citations
18.
York, D. F., E M de Villiers, D. W. Verwoerd, et al.. (1986). Isolation and identification of a South African lentivirus from jaagsiekte lungs.. PubMed. 53(1). 55–62. 24 indexed citations
19.
Quérat, Gilles, Véronique Barban, N. Sauze, et al.. (1984). Highly lytic and persistent lentiviruses naturally present in sheep with progressive pneumonia are genetically distinct. Journal of Virology. 52(2). 672–679. 60 indexed citations
20.
Barban, Véronique, Gilles Quérat, N. Sauze, et al.. (1984). Lentiviruses are naturally resident in a latent form in long-term ovine fibroblast cultures. Journal of Virology. 52(2). 680–682. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia M. Repik Breakdown of academic impact, for papers by Ronald C. Weir Breakdown of academic impact, for papers by Robert B. Tesh Breakdown of academic impact, for papers by Inessa S. Levenbook Breakdown of academic impact, for papers by Marcos S. Freire Breakdown of academic impact, for papers by Mathilde Guerbois Breakdown of academic impact, for papers by Vladimir Yamshchikov Breakdown of academic impact, for papers by Antonio V. Bordería Breakdown of academic impact, for papers by John Catalan Breakdown of academic impact, for papers by Kym Lowry
Rankless by CCL
2026